Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

China Pharma Holdings (CPHI) Assets Average: 2010-2024

Historic Assets Average for China Pharma Holdings (CPHI) over the last 15 years, with Dec 2024 value amounting to $15.7 million.

  • China Pharma Holdings' Assets Average rose 6.65% to $14.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.8 million, marking a year-over-year increase of 6.65%. This contributed to the annual value of $15.7 million for FY2024, which is 8.46% down from last year.
  • China Pharma Holdings' Assets Average amounted to $15.7 million in FY2024, which was down 8.46% from $17.1 million recorded in FY2023.
  • China Pharma Holdings' 5-year Assets Average high stood at $21.9 million for FY2021, and its period low was $15.7 million during FY2024.
  • Moreover, its 3-year median value for Assets Average was $17.1 million (2023), whereas its average is $17.7 million.
  • As far as peak fluctuations go, China Pharma Holdings' Assets Average crashed by 35.88% in 2020, and later grew by 0.96% in 2021.
  • China Pharma Holdings' Assets Average (Yearly) stood at $21.7 million in 2020, then rose by 0.96% to $21.9 million in 2021, then declined by 7.62% to $20.2 million in 2022, then fell by 15.29% to $17.1 million in 2023, then declined by 8.46% to $15.7 million in 2024.